REFERENCES
- Patrick , S W , Schumacher , R E , Benneyworth , B D , Krans , E E , McAllister , J M and Davis , M M . 2012 . Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009 . JAMA. , 307 ( 18 ) : 1934 – 1940 .
- Jones , H E , Kaltenbach , K Heil , S H . 2010 . Neonatal abstinence syndrome after methadone or buprenorphine exposure . N Engl J Med. , 363 ( 24 ) : 2320 – 2331 .
- Lund , I O , Fischer , G Welle-Strand , G K . 2013 . A comparison of buprenorphine +naloxone to buprenorphine and methadone in the treatment of opioid dependence during regnancy: maternal and neonatal outcomes . Subst Abuse. , 7 : 61 – 74 .
- Jones , H E . 2013 . Treating opioid use disorders during pregnancy: historical, current, and future directions . Subst Abus. , 34 ( 2 ) : 89 – 91 .
- Janisse , J J , Bailey , B A , Ager , J and Sokol , R J . 2014 . Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction . Subst Abuse , 35 ( 1 ) : 60 – 67 .
- Smith , L M , LaGasse , L L Derauf , C . 2006 . The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth . Pediatrics. , 118 ( 3 ) : 1149 – 1156 .
- Kiblawi , Z N , Smith , L M Diaz , S D . 2014 . Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study . Subst Abuse , 35 ( 1 ) : 68 – 73 .
- Messaadi , N , Pansu , A , Evezard , H , Debrabant , S , Deruelle , P and Cottencin , O . 2014 . The continued care of pregnant women receiving opiate substitution treatment by midwives . Subst Abuse. , 35 ( 1 ) : 56 – 59 .